BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 102 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,074,000 | +190.3% | 832,898 | +136.2% | 0.00% | – |
| Q3 2019 | $370,000 | -38.5% | 352,585 | -0.6% | 0.00% | – |
| Q2 2019 | $602,000 | -65.6% | 354,660 | -31.6% | 0.00% | – |
| Q1 2019 | $1,748,000 | -41.2% | 518,714 | -49.1% | 0.00% | – |
| Q4 2018 | $2,974,000 | +13.7% | 1,018,620 | +139.8% | 0.00% | -100.0% |
| Q3 2018 | $2,616,000 | -11.4% | 424,793 | +6.1% | 0.00% | 0.0% |
| Q2 2018 | $2,953,000 | +97.9% | 400,232 | +75.9% | 0.00% | – |
| Q1 2018 | $1,492,000 | -20.9% | 227,502 | +1.4% | 0.00% | -100.0% |
| Q4 2017 | $1,887,000 | -26.1% | 224,418 | +1.4% | 0.00% | 0.0% |
| Q3 2017 | $2,555,000 | +8.4% | 221,273 | +9.6% | 0.00% | 0.0% |
| Q2 2017 | $2,357,000 | +6.7% | 201,801 | +12.7% | 0.00% | 0.0% |
| Q1 2017 | $2,209,000 | +6.9% | 179,012 | +17.9% | 0.00% | 0.0% |
| Q4 2016 | $2,067,000 | -36.9% | 151,811 | -7.8% | 0.00% | -50.0% |
| Q3 2016 | $3,276,000 | +211.4% | 164,638 | +102.8% | 0.00% | +100.0% |
| Q2 2016 | $1,052,000 | +74.2% | 81,189 | +25.6% | 0.00% | – |
| Q1 2016 | $604,000 | -52.0% | 64,665 | +4.0% | 0.00% | -100.0% |
| Q4 2015 | $1,259,000 | +38.2% | 62,152 | -0.9% | 0.00% | 0.0% |
| Q3 2015 | $911,000 | -43.1% | 62,698 | -16.7% | 0.00% | 0.0% |
| Q2 2015 | $1,601,000 | -7.2% | 75,286 | +1.0% | 0.00% | 0.0% |
| Q1 2015 | $1,726,000 | – | 74,509 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|